NLS

Global report - June 9, 2025

Lif: “The Council of Ministers’ compromise weakens the EU’s competitiveness”

The EU member states have agreed on a compromise for pharmaceutical legislation, which means, among other things, that the data protection period will remain unchanged at eight years.

Biotech Business - June 2, 2025

Bristol Myers Squibb receives European Commission approval for Opdivo

Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union.

Global report - May 13, 2025

Trump signs executive order directing the pharma industry to lower drug prices

On May 12, US President Trump signed an Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.

Event Highlights - May 13, 2025

From Insight to Impact: Highlights from Anglonordic’s 21st Edition

The Anglonordic Life Science Conference concluded its 21st edition at London’s historic County Hall on April 3rd, 2025. With over 350 registered delegates, the event celebrated over two decades of driving innovation and deepening collaboration across the UK, Nordic region, and Europe. More than ever before, this year showcased the power of cross-border partnerships and set the tone for an even more impactful future in the life sciences.

Global report - May 12, 2025

The US administration freezes new National Science Foundation awards

The policy prevents the NSF from awarding new research grants and from supplying allotted funds for existing grants, such as those that receive yearly increments of money.

Biotech Business - February 14, 2025

StemSight secures EUR 2.3 million in funding

The Finnish biotech company developing stem cell therapies for vision restoration, has raised funding from Voima Ventures, Finnish family offices (Stephen Industries Inc. & Biothom Oy), private investors, and Business Finland.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.